Cantor Fitzgerald Research Analysts Increase Earnings Estimates for Healthequity Inc (HQY)

Healthequity Inc (NASDAQ:HQY) – Cantor Fitzgerald increased their FY2019 earnings per share estimates for Healthequity in a research report issued on Wednesday. Cantor Fitzgerald analyst S. Halper now expects that the company will post earnings per share of $1.00 for the year, up from their prior estimate of $0.90. Cantor Fitzgerald has a “Overweight” rating and a $60.00 price objective on the stock.

Other analysts have also recently issued reports about the company. Citigroup started coverage on Healthequity in a report on Thursday, January 4th. They set a “buy” rating for the company. Chardan Capital lifted their price target on Healthequity from $58.00 to $62.00 and gave the stock a “buy” rating in a report on Wednesday, December 6th. Zacks Investment Research raised Healthequity from a “hold” rating to a “buy” rating and set a $60.00 price target for the company in a report on Wednesday, November 8th. BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a report on Tuesday, November 7th. Finally, Robert W. Baird lifted their price target on Healthequity from $48.00 to $49.00 and gave the stock a “neutral” rating in a report on Wednesday. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $57.17.

Healthequity (NASDAQ:HQY) traded up $0.30 during trading hours on Friday, reaching $51.29. The company had a trading volume of 455,622 shares, compared to its average volume of 481,216. The firm has a market cap of $3,090.00, a PE ratio of 69.31, a P/E/G ratio of 1.93 and a beta of 1.70. Healthequity has a 1-year low of $37.62 and a 1-year high of $55.31.

Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.13 by $0.04. The business had revenue of $56.80 million during the quarter, compared to analysts’ expectations of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The firm’s revenue for the quarter was up 31.0% compared to the same quarter last year. During the same period last year, the firm posted $0.10 EPS.

Several institutional investors and hedge funds have recently modified their holdings of HQY. Eagle Asset Management Inc. bought a new position in shares of Healthequity in the 3rd quarter valued at $36,875,000. Victory Capital Management Inc. grew its position in Healthequity by 116.4% during the 4th quarter. Victory Capital Management Inc. now owns 1,031,711 shares of the company’s stock worth $48,139,000 after acquiring an additional 555,027 shares during the last quarter. Wells Fargo & Company MN grew its position in Healthequity by 49.5% during the 3rd quarter. Wells Fargo & Company MN now owns 1,108,410 shares of the company’s stock worth $56,063,000 after acquiring an additional 366,925 shares during the last quarter. BlackRock Inc. grew its position in Healthequity by 3.8% during the 4th quarter. BlackRock Inc. now owns 6,751,491 shares of the company’s stock worth $315,026,000 after acquiring an additional 244,819 shares during the last quarter. Finally, Amussen Hunsaker & Associates LLC bought a new stake in Healthequity during the 2nd quarter worth $11,598,000. Institutional investors own 98.20% of the company’s stock.

In other Healthequity news, Director Frank Medici sold 700 shares of Healthequity stock in a transaction on Wednesday, November 15th. The stock was sold at an average price of $51.05, for a total value of $35,735.00. Following the completion of the transaction, the director now directly owns 6,381 shares of the company’s stock, valued at approximately $325,750.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Delano Ladd sold 26,405 shares of Healthequity stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $43.32, for a total value of $1,143,864.60. Following the completion of the transaction, the executive vice president now owns 16,692 shares in the company, valued at approximately $723,097.44. The disclosure for this sale can be found here. Insiders sold a total of 371,426 shares of company stock valued at $18,749,703 over the last ninety days. Insiders own 29.00% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Cantor Fitzgerald Research Analysts Increase Earnings Estimates for Healthequity Inc (HQY)” was first posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece can be read at https://www.americanbankingnews.com/2018/02/09/cantor-fitzgerald-research-analysts-increase-earnings-estimates-for-healthequity-inc-hqy.html.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply